Business Context and Reporting Period
This Form 6-K filing by Tower Semiconductor Ltd. covers the month of April 2003. The company is an Israeli semiconductor manufacturer based in Migdal Haemek. The filing primarily announces a Special General Meeting of Shareholders scheduled for May 14, 2003, and reports the receipt of the first volume production order for its new manufacturing facility, Fab 2.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. No financial statements or quantitative performance metrics are included in this document.
Material Changes and Corporate Actions
- Fab 2 Milestone: On April 24, 2003, the company announced its first volume production order for Fab 2.
- Shareholder Meeting Agenda: The upcoming May 14 meeting will address four key items:
- Amendment to Fab 2 investment agreements with partners including ICTech, SanDisk, Alliance Semiconductor, and Macronix.
- Increase in authorized ordinary shares to 100,000,000 and authorized share capital to NIS 100,000,000.
- Appointment of Mr. Carmel Vernia as Chairman of the Board, effective June 1, 2003.
- Appointment of Mr. Carmel Vernia as Acting CEO for a period of up to 3 years, effective June 1, 2003.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, forward-looking revenue projections, or a detailed discussion of risks and contingencies. The primary outlook indicator is the commencement of volume production at Fab 2, suggesting operational progress. The appointment of new leadership (Chairman and Acting CEO) indicates a strategic shift in management.
Key Facts for Investor Verification
- Verify the terms of the amended Fab 2 investment agreements with ICTech, SanDisk, Alliance Semiconductor, and Macronix.
- Confirm the details of the leadership transition, specifically the roles and compensation of Mr. Carmel Vernia as Chairman and Acting CEO.
- Assess the financial impact and volume of the first production order for Fab 2.
- Review the implications of the increased authorized share capital on existing shareholder dilution.